Market Overview

Ignyta to Participate at the Global Mizuho Investor Conference


Ignyta, Inc. (NASDAQ:RXDX), a biotechnology company focused
on precision medicine in oncology, announced today that it will
participate in investor meetings at the Global Mizuho Investor
Conference on December 5, 2017, in New York City.

Investors who wish to meet with the Company's management during this
conference should contact the conference coordinator.

About Ignyta, Inc.

Blazing a New Future for Patients with Cancer™

At Ignyta, we work tirelessly on behalf of patients with cancer to offer
potentially life-saving, precisely targeted therapeutics (Rx) guided by
diagnostic (Dx) tests. Our integrated Rx/Dx strategy allows us to enter
uncharted territory, illuminating the molecular and immunological
drivers of cancer and quickly advancing treatments to address them. This
approach embraces even those patients with rare cancers, who have the
highest unmet need and who may otherwise not have access to effective
treatment options. With our pipeline of potentially first-in-class or
best-in-class precision medicines, we are pursuing the ultimate goal of
not just shrinking tumors, but eradicating cancer relapse and recurrence
in precisely defined patient populations.

For more information, please visit:

View Comments and Join the Discussion!